Lifestyle Modifications and Nutritional and Therapeutic Interventions in Delaying the Progression of Chronic Kidney Disease: A Review

被引:18
|
作者
Alkhatib, Lean [1 ]
Diaz, Lorena A. Velez [2 ]
Varma, Samyukta [3 ]
Chowdhary, Arsh [4 ]
Bapat, Prachi [5 ]
Pan, Hai [6 ]
Kukreja, Geetika [7 ]
Palabindela, Prasannalaxmi [8 ]
Selvam, Sri Abirami [9 ]
Kalra, Kartik [10 ]
机构
[1] Royal Med Serv, Internal Med, Amman, Jordan
[2] Univ Guayaquil, Med, Guayaquil, Ecuador
[3] Madurai Med Coll, Internal Med, Madurai, India
[4] Smt Kashibai Navale Med Coll & Gen Hosp, Nephrol, Pune, India
[5] Smt Kashibai Navale Med Coll & Gen Hosp, Gen Med, Pune, India
[6] Tianjin Univ Chinese Med, Pathol, Tianjin, Peoples R China
[7] Henry Ford Hlth Syst, Internal Med & Hematol Oncol, Clinton Township, MI USA
[8] Jennie Stuart Hlth, Internal Med, Hopkinsville, KY USA
[9] St Mary Hosp, Internal Med, Langhorne, PA USA
[10] Geisinger Med Ctr, Nephrol, Danville, VA USA
关键词
treatment options for diabetic nephropathy; diabetic kidney disease (dkd); chronic kidney disease (ckd); ckd progression; ckd management; CARDIOVASCULAR RISK; SGLT2; INHIBITORS; HYPERTENSION; ASSOCIATION; FINERENONE; MANAGEMENT; OUTCOMES;
D O I
10.7759/cureus.34572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is a debilitating progressive illness that affects more than 10% of the world's population. In this literature review, we discussed the roles of nutritional interventions, lifestyle modifications, hypertension (HTN) and diabetes mellitus (DM) control, and medications in delaying the progression of CKD. Walking, weight loss, low-protein diet (LPD), adherence to the alternate Mediterranean (aMed) diet, and Alternative Healthy Eating Index (AHEI)-2010 slow the progression of CKD. However, smoking and binge alcohol drinking increase the risk of CKD progression. In addition, hyperglycemia, altered lipid metabolism, low-grade inflammation, over-activation of the renin-angiotensin-aldosterone system (RAAS), and overhydration (OH) increase diabetic CKD progression. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend blood pressure (BP) control of <140/90 mmHg in patients without albuminuria and <130/80 mmHg in patients with albuminuria to prevent CKD progression. Medical therapies aim to target epigenetic alterations, fibrosis, and inflammation. Currently, RAAS blockade, sodium-glucose cotransporter-2 (SGLT2) inhibitors, pentoxifylline, and finerenone are approved for managing CKD. In addition, according to the completed Study of Diabetic Nephropathy with Atrasentan (SONAR), atrasentan, an endothelin receptor antagonist (ERA), decreased the risk of renal events in diabetic CKD patients. However, ongoing trials are studying the role of other agents in slowing the progression of CKD.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Lifestyle interventions delivered by eHealth in chronic kidney disease: A scoping review
    Curtis, Ffion
    Burton, James O.
    Butt, Ayesha
    Dhaliwal, Harsimran K.
    Graham-Brown, Matthew M. P.
    Lightfoot, Courtney J.
    Rawat, Rishika
    Smith, Alice C.
    Wilkinson, Thomas J.
    March, Daniel S.
    PLOS ONE, 2024, 19 (01):
  • [2] Effects of Exercise Training on Delaying Disease Progression in Patients with Chronic Kidney Disease: a Review of the Literature
    Izumi, Atsushi
    Kitamura, Masahiro
    Izawa, Kazuhiro P.
    REVIEWS ON RECENT CLINICAL TRIALS, 2016, 11 (04) : 333 - 341
  • [3] Effects of Targeted Interventions on Lifestyle Modifications of Chronic Kidney Disease Patients: Randomized Controlled Trial
    Teng, Hsiu-Lan
    Yen, Miaofen
    Fetzer, Susan
    Sung, Junne-Ming
    Hung, Shih-Yuan
    WESTERN JOURNAL OF NURSING RESEARCH, 2013, 35 (09) : 1107 - 1127
  • [4] Oral adsorbents for preventing or delaying the progression of chronic kidney disease
    Wu, Hong Mei
    Sun, Hong Juan
    Wang, Feng
    Yang, Ming
    Dong, Bi Rong
    Liu, Guan J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [5] Lifestyle behaviour change for preventing the progression of chronic kidney disease: a systematic review
    Evangelidis, Nicole
    Craig, Jonathan
    Bauman, Adrian
    Manera, Karine
    Saglimbene, Valeria
    Tong, Allison
    BMJ OPEN, 2019, 9 (10):
  • [6] The Key Role of Nutritional Intervention in Delaying Disease Progression and the Therapeutic Management of Diabetic Kidney Disease-A Challenge for Physicians and Patients
    Peride, Ileana
    Anastasiu, Miruna
    Serban, Silvia Alexandra
    Tiglis, Mirela
    Ene, Razvan
    Nechita, Ana-Maria
    Neagu, Tiberiu Paul
    Checherita, Ionel Alexandru
    Niculae, Andrei
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (08):
  • [7] AST-120 (KREMEZIN) FOR DELAYING PROGRESSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW
    Gapuz, K.
    Que, F. V.
    Tambunan, B.
    Crisostomo, A.
    Naidas, O.
    NEPHROLOGY, 2013, 18 : 21 - 21
  • [8] Management of chronic kidney disease: An emphasis on delaying disease progression and treatment options
    Crockell, Yvette J.
    FORMULARY, 2012, 47 (06) : 228 - +
  • [9] Probiotics and Fecal Transplant: An Intervention in Delaying Chronic Kidney Disease Progression?
    Sanekommu, Harshavardhan
    Taj, Sobaan
    Mah Noor, Rida
    Umair Akmal, Muhammad
    Akhtar, Reza
    Hossain, Mohammad
    Asif, Arif
    CLINICS AND PRACTICE, 2023, 13 (04) : 881 - 888
  • [10] Lifestyle Interventions, Kidney Disease Progression, and Quality of Life: A Systematic Review and Meta-analysis
    Neale, Elizabeth P.
    Do Rosario, Vinicius
    Probst, Yasmine
    Beck, Eleanor
    Tran, Thai Binh
    Lambert, Kelly
    KIDNEY MEDICINE, 2023, 5 (06)